Bibliografía

1. Reussi, R. y col.: La trombosis profunda y el tromboembolismo pulmonar. Rev Iberoamer Tromb Hemostasia 13:114,2000.
2. Battle, J. y col.: factor Leyden y factor II G20210A en pacientes con enfermedad tromboembólica. Revisión de la situación en España.Re Iberoamer Tromb Hemostasia 12:1,1999
3. Harenberg, J.: Risk assesment of venous thromboembolism in medical patients.Sem Hemat 37 (suppl 5) 3:2000
4. Baglin, T.P. y col.: Fatal pulmonary embolism in hospitalised medical patients.J Clin Pathol 50:609,1997
5. De Moerlose, P. y col.: Screening tests for trombophilic patients: which tests, for which patient, by whom, when and why?. Sem Thromb Hemost 24:321,1998
6. Lane, D.A. y col.: Antithrombin mutation database. 2nd (1997) update.Thromb Haemostas 77:197,1997
7. Siscovick, D.S. y col.: Thrombosis in the young: effect of atherosclerotic risk factors on the risk of myocardial infarction associated with prothrombotic factors. Thromb Haemostas 78:7,1997
8. Michiels, J.J. y col.: Laboratory diagnosis of hereditary thombophilia. Sem Thromb Hemostas 24:309,1998
9. González, G.: Trombofilias relacionadas al sistema anticoagulante de la proteína C. Rev Iberoamer Tromb Hemostasia 10:85,1997
10. Dahlback, B y col. A natural anticoagulant pathway: protein C,S,C4b-BP, and thrombomodulin. En: Bloom al, Forbes C, Thomas,D, Tuddenham, E Eds. Haemostasis and thrombosis. 3ª edicion. Churchill Livingstone. 671, 1994
11. Esmon Ch. Y col.: The protein C pathway: New insights. Tromb Haemost 78:70,1997
12. Aiach, M y col. : A review of mutations causing deficiencies of antithrombin protein C and S. Thromb Haemost 4:81,1995
13. Dahlback, B.: New molecular insights into the genetics of thrombophilia. Thromb Haemost 74:139,1995
14. Borgel, D. y col.: Protein S deficiency. Thromb Haemost 78:351,1997.
15. Mudd, S. H. y col.: The natural history of homocysteinuria due to cystathionine beta-synthetase. Am J Hum Genet 37:1,1985
16. Townend, J. y col: Hyperhomocysteinemia and vascular disease. Blood Rev 12:23,1998
17. Mcdonagh, J. y col.: Dysfibrinogenemia and other disorders of fibrinogen structure and function. En "Hemostasis and Thrombosis". Colman, Hirsch, Marder y Salzman editores. Capítulo 16, pag. 314. J. B. Lippincot co., 3ª edición, 1993.
18. Soria, j. Y col. : Dysfibrinogenemia and thrombosis. Nouv Rev Fr Hematol 33:457,1991
19. Hughes,G.R.V.: The anticardiolipin syndrome. Clin Exp Rhematol 3:285,1985
20. Asherson, R.A. y col.: Catastrophic antiphospholipid syndrome. Clinical and laboratory features
    of 50 cases. Med 77:195,1998
21. Chanarin, I. y col.: Cobalamin-folate interactions. Blood Reviews 3:211,1989
22. Arocha-Piñango, C.L. y col.: Relación del fibrinógeno (fg) y otros parámetros hemostáticos con eventos cardiovasculares isquémicos (eci): revisión de la literatura. Rev Iberoamer Tromb Hemostasia 8:183,1995
23. Smith, S.B. y col. : Cryofibrinogenemia: incidence, clinical correlations and a review of the literature. Am J Clin Path 58:524,1972
24. McKee, P.A. y col.: Incidence and significance of Cryofibrinogenemia. J Lab Clin Med 61:203,1963
25. Sartori, M.T., y col.: Congenital hypoplasminogenemia and thrombosis: a study in 21 patients belonging to five new kindreds. Rev Iberoamer Tromb Hemostasia 7:83,1994
26. Leebeek, F.W.G. y col.: Severe thrombotic tendency associated with a type I plasminogen deficiency. Am J Hematol 30:32,1989
27. Shigetiko, T y col.: Type I congenital plasminogen deficiency is not a risk factor for thrombosis. Thromb Haemost 67:189,1992
28. Hirsch, J. y col.: Approach to the thrombophilic patient. En: Colman, Hirsch, Marder, Salzman eds. Hemostasis and Thombosis. Basic principles and clinical practice. 3ª. Edición. Philadelphia: Lippincot; 1543:1994.
29. Bertina, R.M. y col.: Hereditary heparin co-factor II deficiency and the risk of development of thrombosis. Thromb Haemostas 57:196,1987
30. Koster, T. y col.: John Hageman's factor and deep vein thrombosis: Leyden thrombophilia study. Br J Haematol 87:422,1994
31. De Stefano, V. y col.: The risk of recurrent deep vein thrombosis among heterozygous carriers of both factor V Leyden and the G20210A prothrombin mutation. New Eng J Med 341:801,1999
32. Kyrle, P.A. y col.: High plasma levels of factor VIII and the risk of recurrent thromboembolism. New Eng J Med 343:457,2000
33. Kearon, C. y col.: A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thrombosis. New Eng J Med 340:901,1999
34. Alhene-Gelas, M. y col.: Venous thromboembolic disease and the prothrombin, methylene tetrahydrofolate reductase and factor V genes. thromb Haemost 81:506,1999
35. Seliogsohn, U. y col.: Genetic susceptibility to venous thrombosis. New J. Med 344:1222,2001